Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Receives Average Recommendation of “Buy” from Brokerages

Reckitt Benckiser Group plc (OTCMKTS:RBGLYGet Free Report) has earned a consensus recommendation of “Buy” from the eight research firms that are presently covering the firm, MarketBeat.com reports. Three investment analysts have rated the stock with a hold rating, two have issued a buy rating and three have given a strong buy rating to the company.

Several equities analysts have recently weighed in on RBGLY shares. Barclays lowered shares of Reckitt Benckiser Group from an “overweight” rating to an “equal weight” rating in a report on Tuesday, February 4th. Royal Bank of Canada reiterated an “outperform” rating on shares of Reckitt Benckiser Group in a report on Friday, March 7th.

Read Our Latest Stock Analysis on RBGLY

Reckitt Benckiser Group Stock Performance

RBGLY opened at $12.66 on Friday. Reckitt Benckiser Group has a 52-week low of $10.24 and a 52-week high of $14.10. The firm’s 50-day moving average price is $13.28 and its 200-day moving average price is $12.66. The company has a debt-to-equity ratio of 0.97, a quick ratio of 0.47 and a current ratio of 0.69.

Reckitt Benckiser Group Increases Dividend

The firm also recently declared a dividend, which will be paid on Thursday, June 5th. Shareholders of record on Friday, April 11th will be given a $0.2909 dividend. The ex-dividend date is Friday, April 11th. This is a boost from Reckitt Benckiser Group’s previous dividend of $0.19.

About Reckitt Benckiser Group

(Get Free Report

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

See Also

Analyst Recommendations for Reckitt Benckiser Group (OTCMKTS:RBGLY)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.